SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending after securing a $250 million capital commitment that extends its operational runway to 2028, fueling community debate between those anticipating a major short squeeze as the company shifts to revenue generation, and others worried about continued dilution and fundamental value.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

With its S-4 registration now effective and the merger vote scheduled for February 12, Churchill Capital Corp X (to become Infleqtion) is gaining significant attention. The community is buzzing about its collaboration with NASA on a quantum gravity sensor mission and new energy sector contracts, widely considering the company undervalued compared to peers given its leading neutral-atom technology and existing revenue streams.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Following its recent earnings report, Fiserv is seeing divided community discussion around its perceived deep value and turnaround potential under new leadership, while concerns persist over its debt, shrinking margins, and the broader fintech sector's challenges.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia Technologies is trending following its Q4 earnings report which showcased a massive reduction in cash burn and accelerating growth, with the CEO asserting no capital raise is needed to reach profitability. The community is highly bullish on Jumia's trajectory as the "Amazon of Africa" in a rapidly growing market, further fueled by recent positive analyst coverage and high price targets.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify is rallying after a strong earnings report showcased impressive user and subscriber growth alongside improved profitability and optimistic guidance, prompting analyst upgrades and expectations for higher price targets. The community is actively discussing these strategic gains, even as debate continues around recent subscription price increases and competition in the streaming sector.

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Evommune Inc.

Evommune Inc

Evommune Inc. is seeing significant pre-market momentum following positive top-line data from its Phase 2a trial for EVO301 in moderate-to-severe atopic dermatitis, sparking a polarized community debate between bullish expectations of a short squeeze and warnings of a potential dump at market open.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is generating buzz following its latest earnings report, where a substantial 2026 guidance predicting profitability and record membership growth is fueling a bullish narrative. This optimism directly contrasts with a quarterly financial miss that has skeptics questioning the sustainability of its aggressive forward outlook amidst broader healthcare sector uncertainties.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is a top trending stock following a new joint venture with Americas Gold and Silver to construct a domestic hydromet processing facility for critical minerals, including antimony. The news, amplified by CEO media appearances, is sparking community excitement about bolstering the U.S. supply chain and the potential for a significant short squeeze in the sector.

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Nektar Therapeutics

Nektar Therapeutics is trending after reporting strong 52-week maintenance data for its atopic dermatitis drug, rezpegaldesleukin, demonstrating durable efficacy comparable to or exceeding competitors like Dupixent. The community is buzzing about the drug's potential, with many anticipating higher price targets, a significant short squeeze, and the possibility of a big pharma buyout.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is trending after reporting strong Q4 earnings that initially sent the stock higher, driven by significant client additions and an upbeat outlook. However, these gains were quickly erased as concerns over increased competition in the observability sector, including recent acquisitions by rivals, are actively weighing on community sentiment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gevo Touts North Dakota Carbon Capture, $40M EBITDA Goal, Eyes 2026 SAF Plant FID at Conference

Gevo (NASDAQ:GEVO) outlined its current asset base, near-term earnings priorities, and longer-term plans to scale sustainable aviation fuel production during a virtual investor conference...

Is Western Production a Core Earnings and Growth Pillar for ALTO?

ALTO's Western production unit fuels earnings strength with premium pricing, LCFS tailwinds, and margin resilience.

Gevo (NASDAQ:GEVO) Trading Up 5.6% - Here's Why

Gevo (NASDAQ:GEVO) Trading 5.6% Higher - Should You Buy...

Gevo CEO Shakeup: Gruber to Executive Chair as Bloom Takes Helm, Eyes Northstar ATJ30 Expansion

Executives from Gevo (NASDAQ:GEVO) used a virtual non-deal roadshow hosted by Renmark Financial Communications to discuss a leadership transition and outline operational priorities tied to the...

Is the Pekin Segment the Anchor of Alto Ingredients' Growth Strategy?

ALTO's Pekin segment fuels earnings with high-margin alcohols, diversifying revenues and boosting long-term growth potential.

Gevo, Inc. (NASDAQ:GEVO) Given Consensus Recommendation of "Moderate Buy" by Analysts

Gevo, Inc. (NASDAQ:GEVO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six analysts that are currently covering the firm, MarketBeat reports. One research...

Gevo (NASDAQ:GEVO) Share Price Passes Above 200 Day Moving Average - Here's What Happened

Gevo (NASDAQ:GEVO) Stock Crosses Above Two Hundred Day Moving Average - What's Next...

Why Alto Ingredients Remains Unprofitable Despite Market Leadership

ALTO's cost cuts, carbon strategies, and clean fuel tax credit push haven't been able to turn its market lead into profits yet.

Alto Ingredients Faces Sales Pressure: Is a Turnaround in the Cards?

ALTO eyes a turnaround after years of falling sales, shifting focus to specialty alcohols and CO2 monetization.

Alto Ingredients Surges 45% in a Year: Time to Buy the Stock?

ALTO has soared 45% in a year and is pivoting to specialty alcohols, but valuation and returns raise caution.

Gevo, Inc. is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo and Gevo Development and Agri-Energy. The Gevo segment focuses on the research and development activities related to the future production of isobutanol, including the development of the firm's proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company's isobutanol technology. The Gevo Development and Agri-Energy segment is currently responsible for the operation of its agri-energy facility and the production of ethanol, isobutanol, and related products. The company was founded by Christopher Michael Ryan, Matthew W. Peters, Peter Meinhold, and Frances Hamilton Arnold on June 9, 2005 and is headquartered in Englewood, CO.

Gevo Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $SHOP earnings on Wednesday?

Current Price	$1.87
Prev Close	$1.90
Open	$1.88
Dividend Yield	0.00%
50-Day Moving Average	$2.08
Beta	1.64
Avg. Volume	2.89M
PE Ratio	-9.88

52-Week High	$2.95
52-Week Low	$0.9212
Market Capitalization	$460.39M
EPS (Annual)	-$0.3394
Price to Book	0.98
Revenue Per Employee	$138,647.54
Enterprise Value/EBITDA	N/A

GEVO
Gevo Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GEVO News

GEVOGevo Inc